Blog
June 25, 2020

How Covid-19 Affects the PKD Population- Presented in French

How Covid-19 Affects the PKD Population- Presented in French

WHEN: July 9, 2020 at 7:00PM EDT - 9:00PM EDT

WHERE: From the comfort of your home!

Register Here!

PLEASE NOTE, THIS WEBINAR WILL BE TAKING PLACE AT 7PM EST AND WILL BE PRESENTED IN FRENCH

COVID-19 is a serious health concern and the impact on our lives continues to evolve on a daily basis. In these unprecedented times, individuals with pre-existing conditions need to be especially careful. It is our goal to provide you with up-to-date information as it relates to this virus, and to help ease your mind during this challenging time.

The PKD Foundation of Canada is proud to present this complimentary webinar, How COVID-19 Affects the PKD Community. This webinar will give you the opportunity to ask questions to one of Canada’s leading ADPKD specialists.

Patients and their loved ones are invited to join this webinar to learn about the following topics and more:

  • Am I more likely to get COVID-19 due to ADPKD?
  • Am I more at risk of developing severe complications?
  • How to avoid catching COVID-19?
  • What should I do if I get COVID-19 and have ADPKD?
  • How will treatment of ADPKD change during the COVID-19 pandemic?
  • Are there some medications to avoid or stop taking?

Speaker: Dr Guillaume Bollée

This is a FREE event. All are welcome!

Register Here!

 

About the Speaker: 

Dr Guillaume Bollée is a nephrologist with expertise in the field of hereditary and rare kidney diseases. He is Director of the Kidney Rare Disease Clinic at the Montreal Clinical Research Institute (IRCM).Assessing and treating patients with  polycystic kidney disease  is one of the main focuses of this clinic. Dr. Bollée also practices medicine at the Centre hospitalier de l’Université de Montréal (CHUM) and is an Assistant Clinical Professor in the Department of Medicine at the Faculty of Medicine of the Université de Montréal. He is the author and co-authored of numerous articles including rare and genetic renal diseases issues. Dr Bollée has already participated to several PKDFOC forums.